Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07793929 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

Name: A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide — clinical trial record (NCT07793929)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorKailera

Started2026-09-08

View on ClinicalTrials.gov ↗

The primary objective of the study is to estimate the PK parameters of ribupatide in participants with severe renal impairment or end-stage kidney disease (ESKD) after a single dose of ribupatide subcutaneous (SC) injection compared with participants with normal renal function.

Trial Details

NCT Number	NCT07793929
Lead Sponsor	Kailera
Conditions	End Stage Renal Disease, Renal Impairment, Obesity, Overweight
Enrollment	32 participants
Start Date	2026-09-08
Primary Completion	2028-02-08 (estimated)
Study Completion	2028-02-08 (estimated)
Updated on ClinicalTrials.gov	2026-09-03